Kezar Life Sciences Inc

Explore Kezar Life Sciences’ unique protein‑homeostasis platform and its potential shift into precision oncology, offering investors a fresh growth path.

Kezar Life Sciences Inc. is a biotech company focused on developing treatments for autoimmune disorders by stabilizing protein homeostasis, with a market capitalization of approximately $31 million.

Kezar Life Sciences Inc. is a pioneering biotech company working to transform the treatment of autoimmune disorders by targeting the root causes of these complex conditions.